Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YY1-Induced lncRNA PART1 Enhanced Resistance of Ovarian Cancer Cells to Cisplatin by Regulating miR-512-3p/CHRAC1 Axis
Hongbo Yang, Xuegang Zhang, Li Zhu, et al.
DNA and Cell Biology (2021) Vol. 40, Iss. 6, pp. 821-832
Closed Access | Times Cited: 22

Showing 22 citing articles:

LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 53
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 51
Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions
Rendy Hosea, Sharon Hillary, Shourong Wu, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3506-3506
Open Access | Times Cited: 30
SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
Wujiang Gao, Lu Chen, Lin Li, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis
Bing Li, Ge Lou, Jiahui Zhang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Development and Validation of Prognostic Characteristics Associated With Chromatin Remodeling‐Related Genes in Ovarian Cancer
Guansheng Chen, Wenjing Li, Jiayi Guo, et al.
Cancer Medicine (2025) Vol. 14, Iss. 3
Open Access
A Positive Feedback Loop of lncRNA MIR31HG-miR-361-3p -YY1 Accelerates Colorectal Cancer Progression Through Modulating Proliferation, Angiogenesis, and Glycolysis
Tao Guo, Defeng Liu, Shihao Peng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 25
The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
Ieva Vaicekauskaitė, Rasa Sabaliauskaitė, Juozas Rimantas Lazutka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13670-13670
Open Access | Times Cited: 16
LncRNA HCG18 promotes prostate cancer progression by regulating miR-512-3p/HK-2 axis
Yaru Zhu, Zhijing Wang, Haopeng Li, et al.
Asian journal of urology (2024) Vol. 11, Iss. 4, pp. 575-585
Open Access | Times Cited: 3
Long non‑coding RNA PART1: dual role in cancer
Rui Ran, Chaoyang Gong, Zhiqiang Wang, et al.
Human Cell (2022) Vol. 35, Iss. 5, pp. 1364-1374
Closed Access | Times Cited: 12
Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
Linjiao Chen, Jie Wang, Qian Liu
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Crosstalk between YY1 and lncRNAs in cancer: A review
Xiaoli Wang, Jing Li, Yan-hua Cao
Medicine (2022) Vol. 101, Iss. 49, pp. e31990-e31990
Open Access | Times Cited: 8
A review on the role of long non-coding RNA prostate androgen-regulated transcript 1 (PART1) in the etiology of different disorders
Soudeh Ghafouri‐Fard, Atefeh Harsij, Bashdar Mahmud Hussen, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 4
Therapeutic potential of miRNAs in placental extracellular vesicles in ovarian and endometrial cancer
Yi Zhang, Yunhui Tang, Xinyue Chen, et al.
Human Cell (2023) Vol. 37, Iss. 1, pp. 285-296
Closed Access | Times Cited: 4
Expression and clinical significance of lncRNA PART1 in patients with unexplained recurrent pregnancy loss
Lihua Chen, Hua Su, Wang Wenzhan, et al.
Gynecological Endocrinology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer
Shasha Li, Lulu Wang, Jing Shi, et al.
PeerJ (2024) Vol. 12, pp. e16752-e16752
Open Access
HDAC9 and miR-512 Regulate CAGE-Promoted Anti-Cancer Drug Resistance and Cellular Proliferation
Minjeong Yeon, N S Kwon, Jaewhoon Jeoung, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5178-5193
Open Access
CircFAM188A Regulates Autophagy via miR‐670‐3p and ULK1 in Epithelial Ovarian Carcinoma
Min Yong, Yuhua Zeng, Yuqin Yao, et al.
Cancer Reports (2024) Vol. 7, Iss. 9
Open Access
Salidroside overcomes cisplatin resistance in ovarian cancer via the inhibition of CRNDE-mediated autophagy
Ge Yu, Abiyasi Nanding
Molecular and Cellular Biochemistry (2024)
Closed Access
Placental extracellular vesicles induce ovarian tumour cell death in an ex vivo explant model: possible therapeutic potential
Xinyi Sun, Jiayi Wan, Yi Zhang, et al.
Placenta (2024) Vol. 160, pp. 20-28
Open Access
MicroRNAs and Long Non-coding RNAs as Key Targets
Onur Obut, Pınar Akbaba, Mehmet Ali Balcı, et al.
(2023), pp. 39-76
Closed Access
CircFAM188A regulates autophagy via miR-670-3p and ULK2 of epithelial ovarian carcinoma
Min Yong, Yuhua Zeng, Yuqin Yao, et al.
Research Square (Research Square) (2022)
Closed Access
Page 1

Scroll to top